Presented in Turkey,
Reimburse for. LVADs ,there.
Just a lot of work getting the message around. It's getting around, expecting Europe to be very good in Q1 2014.
US slow but it's renowned for being slow to the charging of many of its doctors.
Not a crane on the San Francisco skyline, don't live there but wonder if the US is in shape for change.
A+ rating for fully implantable C-Pulse 2, huge news, chronic animal trial starting Dec 11, small first in man trial to prove safety then commercial in Europe near term?!
VADs haven't gone exponential, accelerated signings of US and European hospitals first indications C - Pulse will.
Austria/Switzerland, England demand pull not supply push.
Weakness, just traders outsmarting themselves thinking they can make more somewhere else before next catalyst?
TCT moderated discussion after presentations by VADs and C-Pulse.
Number 1 problem for VADs, blood contacting
Number 2 problem exit site infections
Leads to number 3 problem no clear point with VADs when risk /reward is favourable for Class 3 patients.
The obligatory nature of VADs makes the burden very high for patients. If u muck up your batteries your dead.
C-Pulse 2 fully implantable will be available in the time frame you have mentioned for your improved VADs
C-Pulse 2 will have none of the above problems, your improved VADs will still have the above problems.
From listening to the TCT presentations I doubt your VAD trials will proceed for the Class 3 space.
Site acquisition has accelerated for C-Pulse the Heard mentality looks to be getting behind this device.
"The tea party is the only party with common sense in this country". Doesn't say much for the USA because your system of government at this moment is failing and dragging others with no vote down with them. Tea party right in the middle of it. Stop thinking this is an internal US problem.
Its not my system of Gov I don't live in the USA, still stuffs me up, US just over extended themselves with wars, vanity of a great power, just think the tea party is full of equal vanity.
BioVentrix biovnrix best claim is it has comparable results to open heart surgery that removes the scar tissue and decreases the size of the heart. I this surgery widely recommended? Enough said.
German "reimbursement approval" next February, already approved for sale. Start of real commercialisation next FEb
Sentiment: Strong Buy
Landscape without competition
Cost effective for governments, hospitals, surgeons, patients, not sure for cardiologists
Debilitating fatal disease with C-Pulse window of opportunity
Pacemaker like procedure near future
Agree with your 5% = a real 20%
But how can u leave out the vast majority of yhe worlds population?
We have examples now days of world mass market must have products.
Do Medicare/insured patients in the US get refused pacemaker ?
I don't think I'm being reckless, the trials if they have accelerated enrollment will give us a good pointer.
The targets you give are pretty well interim estimations,
I don't think a 5% only market penetration will be credible for much longer,not really credible now, just waiting for confirming indications and you can add noughts to yr targets no to mention unstable angina
Ongo if you are using inside information means you are acting illegally, why would I take advice from someone who is apparently acting illegally and bragging about it???
Have we got a squealing short?
Companies got money , probable strong cash flow next year.
A safe effective device that can access nearLy all of a huge market economically for gov the supplier of cash plus another equallY big angina market on horizon. Think u might be caught bilLybob